277 related articles for article (PubMed ID: 2909549)
1. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures.
Pak CY; Sakhaee K; Zerwekh JE; Parcel C; Peterson R; Johnson K
J Clin Endocrinol Metab; 1989 Jan; 68(1):150-9. PubMed ID: 2909549
[TBL] [Abstract][Full Text] [Related]
2. Effect of intermittent therapy with a slow-release fluoride preparation.
Pak CY; Sakhaee K; Zerwekh JE
J Bone Miner Res; 1990 Mar; 5 Suppl 1():S149-55. PubMed ID: 2339625
[TBL] [Abstract][Full Text] [Related]
3. Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial.
Pak CY; Sakhaee K; Piziak V; Peterson RD; Breslau NA; Boyd P; Poindexter JR; Herzog J; Heard-Sakhaee A; Haynes S; Adams-Huet B; Reisch JS
Ann Intern Med; 1994 Apr; 120(8):625-32. PubMed ID: 8135445
[TBL] [Abstract][Full Text] [Related]
4. Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis.
Pak CY; Adams-Huet B; Sakhaee K; Bell NH; Licata A; Johnston C; Rubin B; Bonnick S; Piziak V; Graham H; Ballard J; Berger R; Fears W; Breslau N; Rubin C
J Bone Miner Res; 1996 Feb; 11(2):160-8. PubMed ID: 8822339
[TBL] [Abstract][Full Text] [Related]
5. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.
Riggs BL; Hodgson SF; O'Fallon WM; Chao EY; Wahner HW; Muhs JM; Cedel SL; Melton LJ
N Engl J Med; 1990 Mar; 322(12):802-9. PubMed ID: 2407957
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures.
Gutteridge DH; Stewart GO; Prince RL; Price RI; Retallack RW; Dhaliwal SS; Stuckey BG; Drury P; Jones CE; Faulkner DL; Kent GN; Bhagat CI; Nicholson GC; Jamrozik K
Osteoporos Int; 2002; 13(2):158-70. PubMed ID: 11908491
[TBL] [Abstract][Full Text] [Related]
7. Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial.
Pak CY; Sakhaee K; Adams-Huet B; Piziak V; Peterson RD; Poindexter JR
Ann Intern Med; 1995 Sep; 123(6):401-8. PubMed ID: 7639438
[TBL] [Abstract][Full Text] [Related]
8. Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy.
Meunier PJ; Sebert JL; Reginster JY; Briancon D; Appelboom T; Netter P; Loeb G; Rouillon A; Barry S; Evreux JC; Avouac B; Marchandise X
Osteoporos Int; 1998; 8(1):4-12. PubMed ID: 9692071
[TBL] [Abstract][Full Text] [Related]
9. Assessment by reflection ultrasound method of the effect of intermittent slow-release sodium fluoride-calcium citrate therapy on material strength of bone.
Zerwekh JE; Antich PP; Sakhaee K; Gonzales J; Gottschalk F; Pak CY
J Bone Miner Res; 1991 Mar; 6(3):239-44. PubMed ID: 2035350
[TBL] [Abstract][Full Text] [Related]
10. Sodium fluoride therapy of postmenopausal osteoporosis.
Kleerekoper M; Mendlovic DB
Endocr Rev; 1993 Jun; 14(3):312-23. PubMed ID: 8319597
[TBL] [Abstract][Full Text] [Related]
11. Fewer bone histomorphometric abnormalities with intermittent than with continuous slow-release sodium fluoride therapy.
Schnitzler CM; Wing JR; Raal FJ; van der Merwe MT; Mesquita JM; Gear KA; Robson HJ; Shires R
Osteoporos Int; 1997; 7(4):376-89. PubMed ID: 9373574
[TBL] [Abstract][Full Text] [Related]
12. Effect of slow-release sodium fluoride on cancellous bone histology and connectivity in osteoporosis.
Zerwekh JE; Hagler HK; Sakhaee K; Gottschalk F; Peterson RD; Pak CY
Bone; 1994; 15(6):691-9. PubMed ID: 7873299
[TBL] [Abstract][Full Text] [Related]
13. Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis.
Pak CY; Sakhaee K; Gallagher C; Parcel C; Peterson R; Zerwekh JE; Lemke M; Britton F; Hsu MC; Adams B
J Bone Miner Res; 1986 Dec; 1(6):563-71. PubMed ID: 3503562
[TBL] [Abstract][Full Text] [Related]
14. Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate.
Ringe JD; Dorst A; Kipshoven C; Rovati LC; Setnikar I
Osteoporos Int; 1998; 8(1):47-52. PubMed ID: 9692077
[TBL] [Abstract][Full Text] [Related]
15. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.
Riggs BL; Seeman E; Hodgson SF; Taves DR; O'Fallon WM
N Engl J Med; 1982 Feb; 306(8):446-50. PubMed ID: 6276746
[TBL] [Abstract][Full Text] [Related]
16. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention.
Budden FH; Bayley TA; Harrison JE; Josse RG; Murray TM; Sturtridge WC; Kandel R; Vieth R; Strauss AL; Goodwin S
J Bone Miner Res; 1988 Apr; 3(2):127-32. PubMed ID: 3213607
[TBL] [Abstract][Full Text] [Related]
17. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
Storm T; Thamsborg G; Steiniche T; Genant HK; Sørensen OH
N Engl J Med; 1990 May; 322(18):1265-71. PubMed ID: 2109197
[TBL] [Abstract][Full Text] [Related]
18. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
Ringe JD; Kipshoven C; Cöster A; Umbach R
Osteoporos Int; 1999; 9(2):171-8. PubMed ID: 10367046
[TBL] [Abstract][Full Text] [Related]
19. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
Pouillès JM; Trémollières F; Ribot C
Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
[TBL] [Abstract][Full Text] [Related]
20. The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.
Hodsman AB; Drost DJ
J Clin Endocrinol Metab; 1989 Nov; 69(5):932-8. PubMed ID: 2793995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
